281 related articles for article (PubMed ID: 19175007)
1. [Three case reports of metastatic germ cell tumors in the lumbar vertebra during first-line chemotherapy].
Dobashi M; Son S; Ikeda M; Fujita T; Matsumoto K; Satoh T; Iwamura M; Baba S
Hinyokika Kiyo; 2008 Dec; 54(12):803-7. PubMed ID: 19175007
[TBL] [Abstract][Full Text] [Related]
2. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine.
Berglund RK; Lyden SP; Tsai EC; Lieberman I; Klein EA
Eur Urol; 2006 Aug; 50(2):372-4. PubMed ID: 16626860
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Yanada S; Ito H; Tomita M; Wada T; Hatano T; Kishimoto K; Egawa S
Hinyokika Kiyo; 2008 Jan; 54(1):43-6. PubMed ID: 18260360
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
Ishioka J; Kageyama Y; Ichiyanagi N; Fukuda H; Higashi Y
Int J Urol; 2007 May; 14(5):455-7. PubMed ID: 17511735
[TBL] [Abstract][Full Text] [Related]
7. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
8. Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
Vaughn DJ; Stadtmauer EA
J Clin Oncol; 2007 Jan; 25(3):239-40. PubMed ID: 17235039
[No Abstract] [Full Text] [Related]
9. Germ-cell tumors.
Kondagunta V; Galsky MD; Sonpavde G
N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969229
[No Abstract] [Full Text] [Related]
10. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
11. Anatomo-surgical aspects after chemotherapy for metastatic germ-cell tumors.
Le Duc A; Le Doze H; Mignot L; Gisselbrecht C; Hoang C
Prog Clin Biol Res; 1985; 203():69-80. PubMed ID: 3008191
[No Abstract] [Full Text] [Related]
12. Germ-cell tumors.
Lorch A; Beyer J; Bokemeyer C
N Engl J Med; 2007 Oct; 357(17):1772-3; author reply 1773-4. PubMed ID: 17969228
[No Abstract] [Full Text] [Related]
13. Germ-cell tumors.
De Giorgi U; Pedrazzoli P; Rosti G; ;
N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969230
[No Abstract] [Full Text] [Related]
14. Recent advances in management of patients with platinum-refractory testicular germ cell tumors.
Kollmannsberger C; Nichols C; Bokemeyer C
Cancer; 2006 Mar; 106(6):1217-26. PubMed ID: 16463389
[TBL] [Abstract][Full Text] [Related]
15. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
Pizzocaro G; Guarneri A
Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
[No Abstract] [Full Text] [Related]
16. [Chemotherapeutic treatment regimens for germinal testicular tumors].
Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
[No Abstract] [Full Text] [Related]
17. A phase I-II trial of intensive chemotherapy (CT) with autologous bone-marrow transplantation (ABMT) in metastatic malignant germ cell tumors of the testis (NSGCTT).
Droz JP; Pico JL; Hayat M; Kamioner D; Gouyette A; Beaujean F
Prog Clin Biol Res; 1985; 203():449-50. PubMed ID: 3008182
[No Abstract] [Full Text] [Related]
18. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
[TBL] [Abstract][Full Text] [Related]
19. Germ-cell tumors.
Shamash J; Stebbing J; Powles T
N Engl J Med; 2007 Oct; 357(17):1771-2; author reply 1773-4. PubMed ID: 17960020
[No Abstract] [Full Text] [Related]
20. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Vaughn DJ
Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
